Unichem Laboratories Ltd. — Major Shareholding Notification 2019

Sep 18, 2019

September 18, 2019

Mr. Pradeep Bhandari Company Secretary & Compliance Officer Unichem Laboratories Ltd Unichem Bhavan. S V Road, Prabhat Estate. Jogeshwari (West), Mumbai, Maharashtra - 400102. Tel.: 022-66888333. Fax.: 022-26784391.

Dear Sir,

Sub: Regulation 29(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

In accordance with Regulation 29 (1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we wish to inform you that the aggregate holdings of the scheme of HDFC Mutual Fund in "Unichem Laboratories Ltd." (the Company) as at the close of the business hours on September 17, 2019 was 5.338% of the paid up equity share capital of the Company (Paid up Equity Share Capital being Rs. 14,08,11,500/- comprising 7,04,05,750 equity shares of Rs. 2/- each).

In compliance with Regulation 29(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, please find attached details of acquisition in the prescribed format in Annexure 1 for disclosure to target company and stock exchanges where the shares of the target company are listed.

Kindly acknowledge receipt of the same.

Thanking you,

Yours faithfully, For HDFC Asset Management Company Limited (Investment Managers for HDFC Mutual Fund)

$\sum$

Dinesh Bhakade AVP - Compliance Encl: As above

CC:

Listing Department

National Stock Exchange of India Ltd. Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051. Tel.: 022-2659 8190, Fax: 022-2659 8191

Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001. Fax: 022-2272 3121

HDFC Asset Management Company Limited A Joint Venture with Standard Life Investments CIN: L65991MH1999PLC123027

Registered Office : "HDFC House", 2nd Floor, H.T. Parekh Marg, 165-166, Backbay Reclamation, Churchgate, Mumbai-400 020 Tel.: 022 - 6631 6333 Fax: 022 - 2204 4304, 6658 0200 Website: www.hdfcfund.com

Annexure-1

Disclosures under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Part-A - Details of the Acquisition

$\sim$ $\sim$ $\sim$ $\sim$ $\sim$ $\sim$ $\sim$ $\sim$
Name of the Target Company (TC)	Unichem Laboratories Ltd.
Name(s) of the acquirer and Persons Acting in	HDFC Mutual Fund:
Concert (PAC) with the acquirer	HDFC Trustee Company Limited A/c-
	HDFC Small Cap Fund
Whether the acquirer belongs to Promoter/	NO.
Promoter group
Name(s) of the Stock Exchange(s) where the shares	BSE Limited
of TC are Listed	National Stock Exchange of India Limited
Details of the acquisition of shares/voting	Number	% w.r.t. total	% w.r.t. total diluted
rights/holding of the Acquirer and PAC		share/voting	share/ voting capital
		capital wherever	of the TC $(**)$
		applicable (*)
Before the acquisition under consideration,
holding of acquirer along with PACs of:
a) Shares carrying voting rights	3,458,559	4.912	N.A
b) Shares in the nature of encumbrance (pledge/	0	$\mathbf{0}$	N.A
lien/non-disposal undertaking/ others)
c) Voting rights (VR) otherwise than by equity	0	0	N.A
shares
d) Warrants/ convertible securities/ any other	0	0	N.A
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category)
Total (a+b+c+d)	3,458,559	4.912	N.A
Details of acquisition
a) Shares carrying voting rights acquired	300,000	0.426	N.A
b) VRs acquired otherwise than by equity shares	0	0	N.A
c) Warrants/convertible securities/any other	0	$\Omega$	N.A
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) acquired
d) Shares in the nature of encumbrance (pledge/	$\theta$	0	N.A
lien/non-disposal undertaking/others) Total (a+b+c+/-d)	300,000	0.426	N.A
After the acquisition, holding of acquirer along
with PACs of:
a) Shares carrying voting rights acquired	3,758,559	5.338	N.A
b) VRs acquired otherwise than by equity shares	0	$\theta$	N.A
Warrants/convertible securities/any other C)	0	$\mathbf{0}$	$_{\mathrm{N.A}}$
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) after acquisition
d) Shares in the nature of encumbrance (pledge/	0	$\theta$	N.A
lien/non-disposal undertaking/others)
Total (a+b+c+d)	3,758,559	5.338	N.A

Mode of acquisition (e.g. open market / public issue / rights issue /preferential allotment / inter-se	Open Market MUTUAL FUND
transfer/encumbrance, etc.)	BHAROSA APNO KA
Salient features of the securities acquired including time till redemption, ratio at which it can be converted into equity shares, etc.	N.A.
Date of acquisition of/ date of receipt of intimation of allotment of shares /VR/ warrants/ convertible securities/ any other instrument that entitles the acquirer to receive shares in the TC.	September 17, 2019
Equity share capital / total voting capital of the TC before the said acquisition	Rs. 14,08,11,500/- comprising 7,04,05,750 equity shares of Rs. 2/- each.
Equity share capital/ total voting capital of the TC after the said acquisition	Rs. 14,08,11,500/- comprising 7,04,05,750 equity shares of Rs. 2/- each.
Total diluted share/ voting capital of the TC after the said acquisition	N.A.

Note: Percentages given above are rounded off to three decimal places.

For HDFC Asset Management Company Limited

(Investment Managers for HDFC Mutual Fund)

$\Rightarrow$

Dinesh Bhakade AVP-Compliance Encl: As above Date: September 18, 2019

Notes:

(*)Total share capital/voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement Total share capital/ voting capital has been taken as per the latest filing to be done by the company to the Stock Exchange under Regulation 31 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.